Hikal has reported 6.1% fall in net profit to Rs 33.86 crore on a 4.7% decline in net sales to Rs 512.75 crore in Q4 FY24 as compared with Q4 FY23.
Total expenditure for the period under review added up to Rs 419.75 crore, down 8.2% YoY. For Q4 FY24, interest outgo was Rs 15.26 crore (up 17.6% YoY) and depreciation charge was Rs 32.34 crore (up 20.5% YoY).
Profit before tax in Q4 FY24 stood at Rs 47.21 crore, down 3% from Rs 48.65 crore in Q4 FY23.
For FY24, Hikal has recorded net profit and net revenue of Rs 69.51 crore (down 11.3% YoY) and Rs 1768.66 crore (down 11.8% YoY), respectively.
Hikal is engaged in the business of pharmaceuticals, crop protection, and specialty chemicals.
The scrip fell 1.15% to currently trade at Rs 283.80 on the BSE.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app